ACC Highlights 2020 - What You Need To Know
Details & Video
Program details and agenda: Select TABS on the left (computer) or SCROLL DOWN (phone)
Overview & Objectives
This program was developed by the Canadian Collaborative Research Network and covers the key clinical trial findings and their implications from ACC 2020. This program is intended for cardiovascular specialists and family physicians from across Canada.
Accreditation
This program is NOT accredited.
Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.
Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio.
Faculty
Faculty
Agenda
Agenda
| Program Chapter | Duration (Min:Sec) |
|---|---|
| Heart Failure | |
| - VICTORIA | |
| - New data from PARAGON-HF | |
| Peripheral artery disease | |
| - VOYAGER-PAD | |
| - COMPASS DM | |
| Lipids | |
| - Homozygous FH | |
| - EPA levels in REDUCE-IT | |
| - New data from ODYSSEY Outcomes | |
| - Evolocumab for HIV patients | |
| Structural heart disease | |
| - Updates in TAVR |
Sponsorship
This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and is supported through an educational grant received from:
GOLD SPONSORS
Amgen Canada Inc.
Bayer Canada
SILVER SPONSORS
HLS Therapeutics
Sanofi Canada
BRONZE SPONSORS
Bristol Meyers Squibb
Links & Resources
Program slides:
This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization. A PDF copy of the slides from this program are available for CCRN members from the CCRN website. Click the link below to be directed to the Resource Library.
Access CCRN Member Resource Library.